Friday Jul 25
Merck KGaA To Begin Construction Of $108 Million China Plant
Next month, Merck KGaA will break ground on its new $108 million Shanghai manufacturing plant, which will be the company's second largest manufacturing facility anywhere in the world.
Thu Jul 24, 2014
Merck targets Asean plants to cut costs
Merck KGaA, a leading German chemical and pharmaceutical company, is looking at setting up production plants in Asean including Thailand to cut costs and cash in on opportunities from the Asean Economic Community .
Thu Jul 17, 2014
Merck KGaA undertakes to assist government
A delegation from the German Chemical and Pharmaceutical company, Merck KGaA has been received in audience by the Prime Minister Head of Government Philemon Yang.
Mon Jul 14, 2014
Merck KGaA Appoints New Global Head Of R&D For Biopharma Division
Merck KGaA's biopharmaceutical division today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.
Sat Jul 12, 2014
Merck KGaA pharma chief says looking at mid-size deals - paper
German chemicals and drugs company Merck KGaA is in the market for mid-size acquisitions to bolster its pharmaceuticals division, the head of that unit told Swiss business paper Finanz und Wirtschaft.
Fri Jul 11, 2014
Five things you didn't know about the new head of EMD Serono
Paris Panayiotopoulos took over as president of Rockland-based EMD Serono last November, replacing James Hoyes , who resigned the position last September after nearly a decade.
Mon Jul 07, 2014
Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer
Threshold initiated a Phase 2 trial with TH-302 for the treatment of advanced non-squamous non-small cell lung carcinoma .
Merck Millipore says Indian lab can boost generics quality
Merck Millipore, the life sciences tools division of Merck KGaA, has launched a solid dose formulation lab in India, its first outside Europe.
Thu Jul 03, 2014
BRIEF-Merck KGaA completes squeeze-out of AZ Electronic
Merck KGaA : * Says completes squeeze-out of AZ Electronic Materials SA * Says expects all major steps of the integration to be completed by the end of We welcome comments that advance the story through relevant opinion, anecdotes, links and data.
Tue Jul 01, 2014
EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
EMD Serono, a subsidiary of Merck KGaA, and Mersana Therapeutics entered an agreement to collaboratively develop next-generation antibody-drug conjugates .
Mon Jun 30, 2014
Deciphera Pharmaceuticals Appoints Oliver Rosen M.D. as Chief Medical Officer
Deciphera Pharmaceuticals, a clinical stage biotechnology company focused on improved kinase inhibitor treatments targeting the tumor microenvironment, today announced the appointment of Oliver Rosen, M.D., as Chief Medical Officer.
DGAP-NVR: Merck KGaA: Release according to Article 26a of the WpHG...
Merck KGaA / Total Voting Rights Announcement 30.06.2014 11:21 Total Voting Rights Announcement according to Article 26a of the WpHG, transmitted by DGAP - a company of EQS Group AG.
Merck KGaA buys Peer+ in bet on dimmable windows
Germany's Merck KGaA , the world's largest maker of liquid crystals, said it is buying the shares it does not already own in Dutch company Peer+ to boost the development of electronically dimmable window panes.